Skip to content

Measurement of biomarkers using existing samples from Phase 1 study of EA3571 in healthy adult subjects

Measurement of biomarkers using existing samples from Phase 1 study of EA3571 in healthy adult subjects (EA3571-CP1)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1050230133
Enrollment
21
Registered
2023-11-21
Start date
2023-12-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic steatohepatitis

Interventions

None listed

Sponsors

Takeuchi Yutaka
Lead Sponsor
EA Pharma Co., Ltd
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Subjects who received multiple doses of placebo-or EA3571 in a Phase 1 study of EA3571 in healthy adult subjects

Exclusion criteria

Exclusion criteria: Subjects who refused to participate in this study

Design outcomes

Primary

MeasureTime frame
Plasma hormone concentration

Contacts

Public ContactYutaka Takeuchi

EA Pharma Co., Ltd

contact_ea@eapharma.co.jp+81-3-6280-9600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026